Training on Using ıInsulin in Patients With Type 2 Diabetes
NCT05915338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2023-06-26
Summary
This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.
Conditions
- Insulin Dependent Diabetes
- Diabetes type2
Sponsors & Collaborators
-
Inonu University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-01-05
- Completion
- 2023-03-30
Countries
- Turkey (Türkiye)
More Related Trials
-
Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
NCT06107153 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
NCT00738153 ·Status: COMPLETED
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus
NCT02220296 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
NCT01597713 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes
NCT02148861 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs
NCT00537277 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
NCT02536859 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
NCT01513590 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
NCT01849289 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
NCT01365507 ·Status: COMPLETED ·Phase: PHASE3
-
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM
NCT02227212 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes
NCT02964104 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
NCT02606357 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus
NCT01542060 ·Status: COMPLETED
-
Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
NCT05545800 ·Status: UNKNOWN ·Phase: PHASE3
-
Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes
NCT01536639 ·Status: COMPLETED
-
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
NCT05362058 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
NCT04760626 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control
NCT00701831 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glulisine in Type 2 Diabetes Mellitus
NCT00310297 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
NCT03359837 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
NCT01159353 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
NCT00715780 ·Status: COMPLETED
-
Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes
NCT01536652 ·Status: COMPLETED
-
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
NCT01796366 ·Status: COMPLETED ·Phase: PHASE1